In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Eucalyptus essential oils Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study of the current state of the global eucalyptus...